XML 74 R55.htm IDEA: XBRL DOCUMENT
v3.22.4

Revenues - Narrative (Details) $ in Millions | 3 Months Ended | 12 Months Ended
--- | --- | ---
Dec. 31, 2022 USD ($) | Dec. 31, 2022 USD ($) segment customer | Dec. 31, 2021 USD ($) customer | Dec. 31, 2020 USD ($) customer
Revenue from Contract with Customer [Abstract] |  |  |  |
Number of operating segments | segment |  | 1 |  |
Revenue from External Customer [Line Items] |  |  |  |
Number of major customers (as defined) accounting for more than 10% of total revenue | customer |  | 3 | 3 | 3
Major customers (as defined) accounting for more than 10% of gross trade receivables | customer |  | 3 | 3 |
Combined trade receivables for all major customers (as defined) as a percentage of net trade receivables | 75.00% | 75.00% | 73.00% |
Percentage of worldwide gross revenues derived from major customers (as defined) on a combined basis |  | 82.00% |  |
Total product sales |  | $ 26,323 | $ 25,979 | $ 25,424
Percentage of net trade receivables due from customers located outside the United States, primarily in Europe | 26.00% | 26.00% | 27.00% |
Total revenues |  | $ 26,323 | $ 25,979 | 25,424
US |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 18,595 | 18,194 | 18,496
ROW [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 7,728 | 7,785 | 6,928
Product sales |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 24,801 | 24,297 | 24,240
Total revenues |  | 24,801 | 24,297 | 24,240
Product sales | US |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 17,743 | 17,286 | 17,985
Product sales | ROW [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 7,058 | 7,011 | 6,255
Enbrel® (etanercept) [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 4,117 | 4,465 | 4,996
Enbrel® (etanercept) [Member] | US |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 4,044 | 4,352 | 4,855
Enbrel® (etanercept) [Member] | ROW [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 73 | 113 | 141
Prolia® (denosumab) [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 3,628 | 3,248 | 2,763
Prolia® (denosumab) [Member] | US |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 2,465 | 2,150 | 1,830
Prolia® (denosumab) [Member] | ROW [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 1,163 | 1,098 | 933
Otezla [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 2,288 | 2,249 | 2,195
Otezla [Member] | US |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 1,886 | 1,804 | 1,790
Otezla [Member] | ROW [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 402 | 445 | 405
XGEVA® (denosumab) [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 2,014 | 2,018 | 1,899
XGEVA® (denosumab) [Member] | US |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 1,480 | 1,434 | 1,405
XGEVA® (denosumab) [Member] | ROW [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 534 | 584 | 494
Aranesp® (darbepoetin alfa) [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 1,421 | 1,480 | 1,568
Aranesp® (darbepoetin alfa) [Member] | US |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 521 | 537 | 629
Aranesp® (darbepoetin alfa) [Member] | ROW [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 900 | 943 | 939
Nplate |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 1,307 | 1,027 | 850
Nplate | US |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 848 | 566 | 485
Nplate | ROW [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues | $ 459 |  | 461 | 365
Repatha (evolocumab) [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 1,296 | 1,117 | 887
Repatha (evolocumab) [Member] | US |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 608 | 557 | 459
Repatha (evolocumab) [Member] | ROW [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 688 | 560 | 428
Kyprolis [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 1,247 | 1,108 | 1,065
Kyprolis [Member] | US |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 850 | 736 | 710
Kyprolis [Member] | ROW [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 397 | 372 | 355
Neulasta® (pegfilgrastim) [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 1,126 | 1,734 | 2,293
Neulasta® (pegfilgrastim) [Member] | US |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 959 | 1,514 | 2,001
Neulasta® (pegfilgrastim) [Member] | ROW [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 167 | 220 | 292
Evenity |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 787 | 530 | 350
Evenity | US |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 533 | 331 | 191
Evenity | ROW [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 254 | 199 | 159
Other products [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 5,570 | 5,321 | 5,374
Other products [Member] | US |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 3,549 | 3,305 | 3,630
Other products [Member] | ROW [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total revenues |  | 2,021 | 2,016 | 1,744
Other revenues [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 1,522 | 1,682 | 1,184
Total revenues |  | 1,522 | 1,682 | 1,184
Other revenues [Member] | US |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 852 | 908 | 511
Other revenues [Member] | ROW [Member] |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 670 | 774 | 673
AmerisourceBergen Corporation [Member] | Product sales |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 15,443 | 14,783 | 14,743
McKesson Corporation [Member] | Product sales |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | 17,305 | 15,187 | 13,779
Cardinal Health, Inc. [Member] | Product sales |  |  |  |
Revenue from External Customer [Line Items] |  |  |  |
Total product sales |  | $ 8,319 | $ 7,681 | $ 7,332

X
- Definition Major customers (as defined) accounting for more than 10% of gross trade receivables. + References No definition available. + Details
Name: | amgn_NumberOfCustomersAccountingForMoreThanTenPercentOfGrossTradeReceivables
Namespace Prefix: | amgn_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of major customers (as defined) accounting for more than 10% of total revenue. + References No definition available. + Details
Name: | amgn_NumberOfCustomersAccountingForMoreThanTenPercentOfRevenue
Namespace Prefix: | amgn_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Combined trade receivables for all major customers (as defined) as a percentage of net trade receivables. + References No definition available. + Details
Name: | amgn_PercentageOfCombinedNetTradeReceivablesFromMajorCustomers
Namespace Prefix: | amgn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage of worldwide gross revenues derived from major customers (as defined) on a combined basis. + References No definition available. + Details
Name: | amgn_PercentageOfCombinedWorldwideGrossRevenuesFromMajorCustomers
Namespace Prefix: | amgn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of net trade receivables due from customers located outside the United States, primarily in Europe. + References No definition available. + Details
Name: | amgn_PercentageOfNetAmountDueFromCustomersLocatedOutsideDomesticLocation
Namespace Prefix: | amgn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 18 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599 + Details
Name: | us-gaap_NumberOfOperatingSegments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 + Details
Name: | us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_ProductMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=amgn_EnbrelMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=amgn_ProliaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=amgn_OtezlaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=amgn_XgevaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=amgn_AranespMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=amgn_NplateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=amgn_RepathaevolocumabMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=amgn_KyprolisMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=amgn_NeulastaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=amgn_EvenityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=amgn_OtherProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=amgn_CustomerOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=amgn_CustomerTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=amgn_CustomerThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |